Posts tagged Psychedelics
Dr. Matthew Johnson | The Popularity of Psychedelics

Since Dr. Matthew Johnson first appeared on 12 Geniuses in September of 2020 to discuss The Future of Psychedelics, popular opinion in favor of this category of drugs has surged and so has the research and potential uses for psilocybin, MDMA, LSD, ayahuasca, and other drugs that fit into the broader category of psychedelics. Dr. Johnson and his research have been critical to fueling these growing trends.

In this interview, Dr. Johnson discusses the advancements in psychedelic research that have been made in the last few years, how favorable public opinion about the use of these once taboo drugs continues to grow, and he closes the conversation with his sobering advice for people who are experimenting on their own with these drugs, going on weekend psychedelic retreats, or even going to South America to have ayahuasca experiences with a shaman.

Dr. Matthew Johnson is Senior Investigator in Psychedelics at Sheppard Pratt and Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University where he is one of the world’s most published scientists on the human effects of psychedelics. He had conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson published psychedelic safety guidelines in 2008, helping to resurrect psychedelic research.

Read More
Season Three Wrap Up

Our theme for Season Three was “The Future” and we had a remarkable group of Geniuses to help us make sense of it. The main lesson we took away is that with time and imagination, the list of impossibilities is a lot smaller than we might think. Both 2020 and this most recent season of 12 Geniuses proved that the unimaginable is definitely not impossible.

For Season Four, we will continue exploring the future and the seemingly impossible. In our first four episodes, we'll look at the future of healthcare education, climate change, and artificial intelligence. Episode One of Season Four will be available on January 12th.

Read More
The Future of Psychedelics with Dr. Matthew Johnson

In this interview, Don MacPherson is joined by Dr. Matthew Johnson, an expert in psychoactive drug effects, addiction, and risk behavior. They discuss clinical research on psychedelics including psilocybin, ayahuasca, DMT, MDMA, LSD, and more. They also dive into the potential therapeutic applications for psychedelics including treating depression, PTSD, and addiction, and improving individual happiness, creativity, and selflessness.

Matthew W. Johnson, Ph.D., Professor at Johns Hopkins, is an expert in psychoactive drug effects, addiction, and risk behavior. He has worked with psychedelics since 2004. He developed and published the first psychedelic treatment of tobacco addiction in 2014. With colleagues, he conducted and published the largest study of psilocybin in cancer distress in 2016. He is Principal Investigator on upcoming psilocybin studies treating opioid addiction and PTSD, and LSD research treating chronic pain.

Read More